Author:
Li Jiabei,Song Mingbao,Jian Zhao,Guo Wenyun,Chen Guozhu,Jiang Guoyan,Wang Juan,Wu Xiaojing,Huang Lan
Publisher
Japan Atherosclerosis Society
Subject
Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine
Reference29 articles.
1. 1) Roth GJ, Majerus PW: The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest, 1975; 56: 624-632
2. 2) Wolff T, Miller T, Ko S: Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med, 2009; 150: 405-410
3. 3) Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N, Jinnouchi H, Sugiyama S, Saito Y; Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes(JPAD) Trial Investigators: Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA, 2008; 300: 2134-2141
4. 4) Juul-Möller S, Edvardsson N, Jahnmatz B, Rosén A, Sørensen S, Omblus R: Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial(SAPAT) Group. Lancet, 1992; 340: 1421-1425
5. 5) Mason PJ, Jacobs AK, Freedman JE: Aspirin resistance and atherothrombotic disease. J Am Coll Cardiol, 2005; 46: 986-993
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献